Veru Inc. Quarterly report pursuant to Section 13 or 15(d)

Contingent Liabilities (Narrative) (Details) - USD ($)		3 Months Ended		6 Months Ended
Contingent Liabilities (Narrative) (Details) - USD ($)	Feb. 29, 2024	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Other Commitments [Line Items]
Product liability insurance, coverage amount		$ 10,000,000.0		$ 10,000,000.0
Research and development expense		2,986,791	$ 17,860,701	4,636,841	$ 38,471,828
Adjustment [Member]
Other Commitments [Line Items]
Research and development expense			$ (5,003,932)		$ (3,137,154)
Commercial Dispute [Member]
Other Commitments [Line Items]
Amount supplier claimed was owed	$ 10,000,000
Accounts payable	8,300,000	900,000		900,000
Other liabilities		5,000,000.0		5,000,000.0
Commercial Dispute [Member] \| Adjustment [Member]
Other Commitments [Line Items]
Research and development expense		$ (600,000)		$ (600,000)
Payable Upon Execution Of Agreement [Member] \| Commercial Dispute [Member]
Other Commitments [Line Items]
Accounts payable	2,300,000
Payable In Equal Monthly Installments Over 48 Months [Member] \| Commercial Dispute [Member]
Other Commitments [Line Items]
Accounts payable	$ 3,500,000
Payable term	48 months
Payable On Or Prior To December 31, 2025 [Member] \| Commercial Dispute [Member]
Other Commitments [Line Items]
Accounts payable	$ 2,500,000
All Or Portion Outstanding As Of December 31, 2025 [Member] \| Commercial Dispute [Member]
Other Commitments [Line Items]
Payable term	24 months